Sequenom Posts 62 Percent Jump in Q2 Revenues, Inks Licensing Deal with Mayo Clinic | GenomeWeb

NEW YORK (GenomeWeb) – Sequenom reported after the close of the market on Tuesday that its diagnostic revenues in the second quarter increased 62 percent year over year.

For the three months ended June 30, the San Diego-based company pulled in $39.8 million, all from its Sequenom Center for Molecular Medicine business, compared to diagnostic revenues of $24.5 million in Q2 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Apr
13
Sponsored by
SeraCare

In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay. 

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.